dextrothyroxine has been researched along with ganciclovir in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Bird, D; Francis, JM; Gautam, A; Ingalls, R; Kabbani, D; Kwah, J; Nuhn, M; Roseman, DA | 1 |
| Bastide, C; Bruyère, F; Chandenier, J; Desoubeaux, G; Fourcade, C; Guy, L; Karsenty, G; Lachaud, L; Lavigne, JP; Malavaud, S; Sotto, A | 1 |
| Ashida, C; Funauchi, M; Kinoshita, K; Nozaki, Y | 1 |
| Fartoukh, M; Guitard, J; Le Pogam, A; Lopinto, J; Pecriaux, A; Voiriot, G | 1 |
1 review(s) available for dextrothyroxine and ganciclovir
| Article | Year |
|---|---|
[Non-antibiotic anti-infectious treatments in urology].
Topics: Acyclovir; Albendazole; Amphotericin B; Anti-Infective Agents; Caspofungin; Cidofovir; Cytosine; Echinocandins; Fluconazole; Flucytosine; Foscarnet; Ganciclovir; Humans; Ivermectin; Lipopeptides; Organophosphonates; Praziquantel; Urologic Diseases; Valganciclovir | 2013 |
4 other study(ies) available for dextrothyroxine and ganciclovir
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Strongyloides stercoralis transmission by kidney transplantation in two recipients from a common donor.
Topics: Adult; Albendazole; Animals; Ganciclovir; Humans; Immunocompromised Host; Ivermectin; Kidney Transplantation; Malabsorption Syndromes; Male; Middle Aged; Strongyloides stercoralis; Strongyloidiasis; Tissue Donors; Transplantation, Homologous; Valganciclovir | 2013 |
Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
Topics: Aged; Animals; Anthelmintics; Antiviral Agents; Coinfection; Cytomegalovirus; Cytomegalovirus Infections; Fatal Outcome; Female; Ganciclovir; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Ivermectin; Lupus Erythematosus, Systemic; Strongyloides stercoralis; Strongyloidiasis; Syndrome | 2020 |
Strongyloides stercoralis disseminated infection in an HIV-infected adult.
Topics: Aged; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Antiparasitic Agents; Cefotaxime; DNA, Protozoan; Escherichia coli; Escherichia coli Infections; Feces; Ganciclovir; HIV Infections; Humans; Ivermectin; Male; Strongyloides stercoralis; Strongyloidiasis | 2020 |